![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 03, 2007 5:55:21 PM
The fact that DNAG had a 3 year alliance with Moffitt which has since been terminated with no press releases proclaiming any successful results from that alliance raises more negative questions for consideration. I suggested that Yeatman may be distancing himself and the M2GEN deal from DNAG because there has been no press release indicating how the valuable predictive and therasnostic protocols of DNAG will be a valuable adjunct to the anticipated personalized medicine initiatives for cancer therapy contemplated for M2GEN. If DNAG is as indispensible to M2GEN as you have apparently represented, then my comments should be extremely relevant for your consideration.
JMHO
dr f
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM